United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Apr 26
 +1.10 / +1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 108.00, with a high estimate of 234.00 and a low estimate of 95.00. The median estimate represents a -2.59% decrease from the last price of 110.87.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in United Therapeutics Corp. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 677.68%
Growthannually 24.40%


Growthquarterly -24.23%
Growthannually -15.84%
Key to the earnings and sales forecast charts.